Huberman Lab

Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

March 9, 2026

Key Takeaways Copied to clipboard!

  • The immune system relies on the adaptive branch, featuring T cells and B cells, which generate highly diverse, randomly generated receptors/antibodies to recognize foreign threats, a process educated in the thymus. 
  • Cancer is fundamentally a genetic disease resulting from the accumulation of mutations that cause cells to lose normal regulation and divide uncontrollably, a process accelerated by mutagens like smoking and UV radiation. 
  • Modern medicine is experiencing a revolutionary acceleration due to the convergence of understanding the immune system and developing precise genetic tools like CRISPR, enabling engineered cell therapies such as CAR T-cells to treat previously intractable cancers. 
  • The initial success of CAR T-cell therapy targeting CD19 for B-cell leukemias is partly due to the fact that the collateral damage of eliminating healthy B cells is tolerable for the body. 
  • CRISPR technology, originally a bacterial immune system, has revolutionized biology by providing a highly programmable and precise tool for cutting and editing DNA sequences, which is now being leveraged in advanced cell therapies. 
  • The future of genetic modification is moving beyond simple DNA cutting (scissors) to more predictable editing methods like base editing and epigenetic editing (epi-editing) to mitigate risks associated with double-stranded breaks. 
  • CAR T-cells engineered to eliminate B cells are showing incredible early responses in clinical trials for autoimmune diseases like lupus and rheumatoid arthritis. 
  • The ability to perform large-scale CRISPR screens in primary human T cells, measuring the consequences of inactivating every gene via single-cell RNA sequencing, is providing a functional roadmap for next-generation immunotherapies. 
  • The combination of epigenetic programming (Yamanaka factors) and genetic programming (CRISPR) creates the potential for highly programmable cells capable of regeneration or precise disease targeting, such as immune surveillance against cancer. 

Segments

CAR T-Cells and Immune Engineering
Copied to clipboard!
(00:00:00)
  • Key Takeaway: Engineered T cells, known as CAR T-cells, utilize a lab-designed receptor to program them to specifically search for and destroy cancer cells upon reinfusion.
  • Summary: CAR T-cells involve inserting a gene encoding a chimeric antigen receptor (CAR) into a patient’s T cells. This non-natural receptor directs the reinfused T cells to target cancer cells, similar to a blood transfusion process. This technology represents a major advancement in reprogramming the immune system against malignancies.
Biology’s Accelerated Timeline
Copied to clipboard!
(00:02:40)
  • Key Takeaway: Biology and medicine are experiencing a step-function acceleration due to the convergence of advanced DNA sequencing, computational tools, and the ability to intervene by rewriting specific DNA sequences.
  • Summary: There is a material difference in current biological understanding, allowing intervention at the root causes of disease. This progress is fueled by the ability to test genes at scale and extract insights from massive datasets using computational sophistication. Medicine is now programming cellular behavior with unprecedented direction using tools like CRISPR and lipid nanoparticles.
Innate vs Adaptive Immunity
Copied to clipboard!
(00:05:56)
  • Key Takeaway: The innate immune system acts as the first alarm using cells like macrophages to detect general foreign patterns, triggering the recruitment of the adaptive immune system.
  • Summary: The immune system’s core job is recognizing ‘us versus non-us’ to protect against foreign invasions. Innate immune cells sense general signs of damage or foreign presence and release signals to recruit the adaptive system. The adaptive system is primarily composed of lymphocytes, including B cells and T cells.
T Cell Receptor Generation
Copied to clipboard!
(00:08:33)
  • Key Takeaway: T cells generate unique receptors through probabilistic gene recombination, allowing the immune system to potentially recognize pathogens it has never encountered.
  • Summary: T cells create their own receptors by randomly recombining pieces of DNA, resulting in incredible diversity where each cell has a unique sensor. This probabilistic generation means the body maintains a library of sensors ready for novel threats. The thymus educates these T cells through positive and negative selection to ensure they recognize foreign targets but not self-antigens.
Immune Health Determinants
Copied to clipboard!
(00:16:12)
  • Key Takeaway: Systemic health factors, such as metabolic state induced by diet, can cause qualitative differences in immune responses, which are still underexplored in rigorous mechanistic studies.
  • Summary: While sleep is known to support the immune system, the precise determinants of immune robustness are still being explored, often being left out of standard mouse studies. High-fat diets causing obesity led to allergic reactions that responded differently to standard blocking antibodies compared to normal diet mice. The immune system constantly balances the need for strong infection response against preventing autoimmunity.
Autoimmunity and Immune Balance
Copied to clipboard!
(00:22:23)
  • Key Takeaway: Autoimmune diseases arise when the delicate balance of T cell selection fails, leading to immune cells inappropriately targeting the body’s own tissues, manifesting in conditions like diabetes or MS.
  • Summary: Autoimmunity occurs when T cells that recognize self-antigens escape the thymus’s negative selection process, often due to failures in secondary control mechanisms. The immune system must balance being strong enough to fight infection while remaining tolerant of self-tissues. Therapeutic goals for autoimmunity involve targeted control rather than blanket immunosuppression.
Systemic Immune Signaling
Copied to clipboard!
(00:25:38)
  • Key Takeaway: Systemic immune responses, like those felt during a cold, are coordinated by chemical signals called cytokines secreted into the bloodstream, which can induce effects like fever.
  • Summary: The determination between a localized and systemic immune response depends partly on the invasiveness of the pathogen. Immune cells secrete cytokines that act as distributed signals throughout the body, influencing systemic symptoms like fever. The negative consequences of illness are often due to the immune response overshooting its necessary strength.
Antibiotics and Immune Work
Copied to clipboard!
(00:28:40)
  • Key Takeaway: Using antibiotics for bacterial infections is a miraculous tool that saves lives by short-circuiting the infection, and this intervention does not inherently prevent the immune system from building robustness over a lifespan.
  • Summary: Antibiotics are highly effective tools for treating bacterial infections that would have been deadly in previous generations. Overuse risks creating antibiotic-resistant bacteria, which is an underfunded area of medicine. Allowing the immune system to fight off every infection is not necessary for building a robust immune system.
Cancer: A Genetic Evolution
Copied to clipboard!
(00:30:52)
  • Key Takeaway: Cancer is a genetic disease where cells accumulate mutations that lead to uncontrolled division, and this evolutionary process is accelerated by mutagens or inherited predispositions like BRCA mutations.
  • Summary: Cancer cells lose normal regulation because accumulated DNA mutations grant them a growth advantage over healthy cells. This process is sped up by exposure to mutagens, with smoking and UV light being major factors, or by inheriting predispositions like BRCA genes. Cancer risk generally increases with age because there is more time for these necessary mutations to accumulate.
Mutagens and Risk Assessment
Copied to clipboard!
(00:42:34)
  • Key Takeaway: Environmental factors like pesticides are implicated in cancer risk spikes, and assessing the danger of common exposures like charred meat or food dyes requires weighing high-concentration lab data against real-world, low-level exposure.
  • Summary: Chemical exposures from workplace hazards or environmental sources like pesticides represent real mutagenic risks, though the data for many common exposures remains unclear. The char on barbecued meat contains compounds that are likely mutagenic, requiring individuals to weigh pleasure against risk. Distinguishing between high-dose animal study results and actual human risk from trace exposures like food dyes is a major source of public confusion.
Immunotherapy and Checkpoint Inhibitors
Copied to clipboard!
(00:49:34)
  • Key Takeaway: Immunotherapy drugs, such as checkpoint inhibitors targeting PD-1, unleash the body’s existing T cells against cancer by removing natural inhibitory ‘brakes’ on the immune response.
  • Summary: The dogma against cancer immunology has been overturned by treatments that harness the immune system’s precision. Checkpoint inhibitors remove molecular brakes on T cells, leading to dramatic responses in cancers like melanoma, even when metastatic. This approach aims for durable responses by leveraging the immune system’s ability to distinguish self from non-self.
CRISPR-Engineered CAR T-Cells
Copied to clipboard!
(00:54:54)
  • Key Takeaway: CRISPR technology allows for precise genetic modification of T cells to create highly specific CAR T-cells capable of overcoming cancer’s evasive tactics in solid tumors.
  • Summary: Unlike older lentiviral methods, CRISPR enables targeted DNA changes in T cells to encode artificial sensors (CARs) for superior cancer targeting. This technology has shown miraculous success in childhood leukemias and is now being advanced to tackle solid tumors, which require additional edits to resist the tumor’s immunosuppressive environment. The goal is to create T cells that are more precise and durable than chemotherapy.
CAR T-Cells and CD19 Targeting
Copied to clipboard!
(01:02:21)
  • Key Takeaway: Collateral damage to healthy B cells is a tolerable side effect in CD19-targeted CAR T-cell therapy because the body can live without those cells.
  • Summary: CAR T-cells targeting CD19 successfully attack B-cell leukemias, but they also eliminate healthy B cells that express CD19. This collateral damage is surprisingly well-tolerated, making the treatment safe and effective. For other cancers, finding targets present only on cancer cells, not healthy tissue, is significantly more challenging.
Ketogenic Diets and Cancer
Copied to clipboard!
(01:07:07)
  • Key Takeaway: The efficacy of ketogenic or low-carb diets for cancer treatment or prevention remains inconclusive, potentially helping some cancers while worsening others.
  • Summary: There was significant past enthusiasm for ketogenic diets in cancer treatment, but current understanding suggests they might only help certain cancers, while potentially making others worse. Low-glutamine diets are also being explored in this context. Experts suggest these dietary interventions might help through indirect mechanisms but are unlikely to solve the core problem of cancer.
CRISPR Discovery and Mechanism
Copied to clipboard!
(01:08:27)
  • Key Takeaway: CRISPR functions as a repurposed bacterial immune system that uses an RNA molecule to guide the Cas9 protein (the scissor) to precisely cut specific DNA sequences.
  • Summary: CRISPR was discovered as a defense mechanism bacteria use against viruses by recognizing and cutting viral DNA sequences. The system relies on a protein (like Cas9) paired with a programmable RNA molecule that dictates the exact DNA target for the cut. This ability to target and cut DNA at will allows scientists to delete, paste, or replace genes to study function or correct disease-causing mutations.
CRISPR Precision and Evolution
Copied to clipboard!
(01:17:17)
  • Key Takeaway: While early CRISPR systems caused double-stranded breaks with potential off-target risks, newer iterations like base editors and epi-editors avoid cutting DNA entirely.
  • Summary: Early CRISPR precision was limited by off-target cuts and bystander effects, necessitating a risk-benefit analysis for any therapeutic application. Newer technologies, such as CRISPR-based editors developed by David Liu, use the targeting mechanism to recruit enzymes that change nucleotides without creating a double-stranded break. Epi-editing further advances this by using CRISPR to recruit epigenetic enzymes to turn genes on or off without altering the underlying DNA sequence.
Sponsor Break: LMNT
Copied to clipboard!
(01:20:57)
  • Key Takeaway: Adequate hydration and proper electrolyte balance (sodium, magnesium, potassium) are vital for optimal cognitive and physical performance.
  • Summary: Element (LMNT) is an electrolyte drink formulated without sugar, containing essential electrolytes in correct ratios. Proper electrolyte intake is critical because even mild dehydration can diminish cognitive and physical function. Drinking electrolytes upon waking and during exercise supports nerve cell function and overall hydration.
CRISPR Cell Delivery Methods
Copied to clipboard!
(01:22:17)
  • Key Takeaway: Delivery of CRISPR components into cells is achieved through various methods, including electroporation of purified protein/RNA complexes and engineered viruses or lipid nanoparticles (LNPs).
  • Summary: For T-cells, early CRISPR delivery involved electroporation—using electrical currents to temporarily create pores in the cell membrane to allow the Cas9 protein and guide RNA to enter. This technique has been optimized for high efficiency in T-cells, enabling the introduction of large DNA sequences to create enhanced CAR T-cells. Lipid nanoparticles (LNPs), famously used in mRNA vaccines, are also being engineered with targeting molecules to deliver genetic material directly to specific cells in vivo, such as T-cells.
Immunotoxins and T-Cell Engagers
Copied to clipboard!
(01:49:39)
  • Key Takeaway: Modular drug delivery systems, including immunotoxins, antibody-drug conjugates, and T-cell engagers (Bi-specifics), leverage targeting molecules to concentrate therapeutic effects at cancer sites.
  • Summary: Immunotoxins attach a potent toxin to an antibody that recognizes a cancer cell surface protein, delivering a lethal payload locally. Antibody Drug Conjugates (ADCs) similarly use antibodies to deliver drugs or radioactive isotopes specifically to tumor cells, minimizing systemic toxicity. T-cell engagers are two-headed antibodies that physically bridge a T-cell and a cancer cell, activating the immune response without needing genetic modification of the T-cell.
AI Protein Design and Future Targets
Copied to clipboard!
(01:54:24)
  • Key Takeaway: Artificial intelligence is increasingly used to design novel, synthetic protein engagers that recognize specific targets on cancer cells, accelerating the modular construction of therapeutics.
  • Summary: The development of bispecific T-cell engagers is moving beyond traditional animal-derived antibodies toward AI-designed synthetic proteins. These AI models can create novel protein structures designed to bind precisely to any known target on a cancer cell surface. This capability accelerates the creation of modular, multi-faceted therapeutic agents for drug or cell delivery.
Ethics of Heritable Gene Editing
Copied to clipboard!
(01:55:45)
  • Key Takeaway: There is a strong ethical consensus against introducing heritable genetic edits into the human germline (sperm, eggs, or embryos) due to risks of unintended consequences and loss of human diversity.
  • Summary: The modification of human embryos, such as the case involving CCR5 deletion to confer HIV resistance, is widely condemned because these edits are passed to future generations (germline editing). Somatic edits, which only affect individual cells and are not inherited, are ethically distinct and are the focus of current cancer therapies. Concerns exist that editing embryos based on probabilistic traits could lead to fads and reduce essential human genetic diversity.
Future of Immunotherapy and Autoimmunity
Copied to clipboard!
(02:10:44)
  • Key Takeaway: CAR T-cell technology, initially developed for cancer, is showing remarkable early promise in treating autoimmune diseases by selectively eliminating the pathogenic B cells responsible for the condition.
  • Summary: The same CAR T-cells engineered to eliminate B-cell leukemias are now being tested to treat autoimmune diseases like lupus by targeting and removing the problematic B cells. This represents a major therapeutic breakthrough for autoimmunity, leveraging existing cancer technology. Researchers are also developing next-generation delivery systems, including in-vivo CRISPR modification, to make these advanced therapies more accessible.
CAR T-Cells for Autoimmunity
Copied to clipboard!
(02:11:50)
  • Key Takeaway: CAR T-cells targeting B cells are effectively treating autoimmune diseases by eliminating pathogenic B cells.
  • Summary: CAR T cells designed to eliminate B cell leukemias are simultaneously showing incredible responses in early trials for autoimmune diseases like lupus. This occurs because the same B cells contributing to autoimmunity are being cleared by the engineered T cells. Trials are also being considered for rheumatoid arthritis, childhood diabetes, and multiple sclerosis.
Advancements in CRISPR Screening
Copied to clipboard!
(02:14:14)
  • Key Takeaway: CRISPR delivery efficiency in T cells has dramatically improved, enabling massive genetic screens.
  • Summary: The ability to routinely perform CRISPR experiments, delivering tens of thousands of different CRISPRs into a population of T cells, has advanced significantly since 2013. Researchers can now race these modified cells against each other in tumor environments to identify genetic characteristics favorable for cancer defense. This allows for direct learning of genetic modifications that endow T cells with desired therapeutic powers.
Single-Cell RNA Sequencing Utility
Copied to clipboard!
(02:15:41)
  • Key Takeaway: Single-cell RNA sequencing maps the functional consequences of every gene inactivation in T cells.
  • Summary: Researchers can now simultaneously measure the RNA state of individual cells alongside the specific CRISPR modification they received. This technology allows for the inactivation of every gene in the genome to read out the consequences on the cell’s overall state. This creates a functional map, serving as an instruction manual for engineering future T cell immunotherapies with precision and endurance.
Banking T Cells and iPSCs
Copied to clipboard!
(02:17:58)
  • Key Takeaway: Banking T cells or induced pluripotent stem cells (iPSCs) is generally not recommended for the average person currently.
  • Summary: The speaker is not currently advising people to bank their T cells, as researchers hope to re-engineer existing T cells in the future, except perhaps in edge cases where chemotherapy depletes them. Induced pluripotent stem cells (iPSCs), which can be reverted from skin cells, offer a potential limitless supply of cells, negating the need for banking if they can be easily generated and differentiated when needed.
Intersection of Cell Programming
Copied to clipboard!
(02:21:28)
  • Key Takeaway: Combining epigenetic programming with CRISPR genetic programming enables the creation of fully programmable cells.
  • Summary: The ability to epigenetically program a cell’s state (via Yamanaka factors) and genetically program it (via CRISPR) creates the potential for programmable cells. This intersection allows scientists to dial in and direct cellular behavior for regeneration or for immune surveillance to address the root cause of disease. The speaker finds the intersection of these technologies with immunology particularly exciting.
Podcast Wrap-up and Support
Copied to clipboard!
(02:24:42)
  • Key Takeaway: Support for the Huberman Lab podcast includes subscribing, following, leaving reviews, and checking sponsors.
  • Summary: Zero-cost support methods include subscribing on YouTube and following the podcast on Spotify and Apple, where reviews and comments are also welcome. Listeners can find links to Dr. Alex Marson’s work in the show notes and are encouraged to check out the sponsors. Andrew Huberman’s book, ‘Protocols, an operating manual for the human body,’ is available for pre-sale at protocolsbook.com.